Galapagos (NASDAQ: GLPG)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Galapagos Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Galapagos Company Info
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
News & Analysis
Why Galapagos Trounced the Market Today
A high-profile healthcare industry executive has been tapped as the company's new CEO.
Here's Why Galapagos Stock Is Falling Today
The company's new salt-inducable kinase inhibitor program is getting off to a rocky start.
Is Galapagos Stock a Bad-News Buy Right Now?
Despite some serious setbacks, this beaten-down biotech could be a terrific bargain at recent prices.
Why Galapagos Stock Is Crashing Today
The FDA dealt the biotech and its big partner a huge setback.
3 Biotech Stocks With Big Incoming Catalysts
Binary events could send shares of these stocks screaming higher, or lower, soon.
Better Buy: Vertex Pharmaceuticals vs. Galapagos
Is an industry leader in treating cystic fibrosis or a company with a potential miracle drug the better buy for investors?
Galapagos and Gilead Sciences Post Successful Yet Disappointing Filgotinib Results
In a phase 2b/3 study in ulcerative colitis, the drug candidate met its goals, but with results that didn't appear better than those of a potential competitor.
Is Galapagos Stock a Buy?
Investors may want to own this biotech before its lead drug gets approved.
Valuation
Earnings Transcripts
Galapagos NV (GLPG) Q3 2021 Earnings Call Transcript
GLPG earnings call for the period ending September 30, 2021.
Galapagos NV (GLPG) Q2 2021 Earnings Call Transcript
GLPG earnings call for the period ending June 30, 2021.
Galapagos NV (GLPG) Q1 2021 Earnings Call Transcript
GLPG earnings call for the period ending March 31, 2021.
Galapagos NV (GLPG) Q4 2020 Earnings Call Transcript
GLPG earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.